Related Experiment Video
Updated: Aug 13, 2026
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
Commentary: targeting colorectal cancer through molecular biology
1Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA. rkumar@mdanderson.org
Abstract:
Multiple growth factor receptor pathways are deregulated in colon cancer, presenting potential targets for therapeutic intervention. In colon cancer cells, epithelial growth factor receptor activation is associated with the potential for deregulation of both angiogenesis and motility-related characteristics as cell cytoskeleton and cell-cell junction structure. Growth factor activation of receptors can result in increased cyclooxygenase-2 (COX-2) expression and consequent upregulation of prostaglandin E2; this, in turn, results in localization of urokinase proteolytic activity that promotes directional motility and invasiveness of cancer cells. Optimal therapeutic strategies to inhibit cancer cell motility, invasiveness, and angiogenesis may involve combinations of growth factor receptor inhibitors, COX-2 inhibitors, and urokinase inhibitors.
Insights
Colon cancer involves deregulated growth factor pathways. Targeting these pathways, along with cyclooxygenase-2 (COX-2) and urokinase, may inhibit cancer cell motility and angiogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Deregulation of multiple growth factor receptor pathways is common in colon cancer.
- Epithelial growth factor receptor activation influences angiogenesis and cancer cell motility.
- This activation can lead to increased cyclooxygenase-2 (COX-2) and prostaglandin E2, promoting cancer cell invasiveness.
Purpose of the Study:
- To explore the role of growth factor receptor pathways in colon cancer progression.
- To identify potential therapeutic targets for inhibiting colon cancer cell motility and invasiveness.
- To investigate the interplay between growth factor receptors, COX-2, and urokinase in colon cancer.
Main Methods:
- Analysis of growth factor receptor signaling in colon cancer cells.
- Investigation of the effects of growth factor activation on angiogenesis and cell motility markers.
- Examination of COX-2 expression and prostaglandin E2 levels in response to growth factor stimulation.
- Assessment of urokinase localization and proteolytic activity in relation to cancer cell invasiveness.
Main Results:
- Growth factor receptor deregulation is implicated in colon cancer.
- Epithelial growth factor receptor activation affects angiogenesis and cell motility.
- Growth factor signaling upregulates COX-2 and prostaglandin E2, enhancing cancer cell invasiveness.
- Urokinase activity is linked to enhanced cancer cell motility and invasiveness.
Conclusions:
- Combined inhibition of growth factor receptors, COX-2, and urokinase may be an effective therapeutic strategy.
- Targeting these pathways offers a promising approach to inhibit colon cancer cell motility, invasiveness, and angiogenesis.
- Understanding these molecular mechanisms is crucial for developing optimal colon cancer treatments.
